Patent: 10,478,478
✉ Email this page to a colleague
Summary for Patent: 10,478,478
Title: | Treatment of Raynaud\'s phenomenon using botulinum toxin type B |
Abstract: | An effective amount of botulinum toxin type B is administered to a subject in need thereof for treating Raynaud\'s phenomenon. Botulinum toxin type B may be in a form of an injection, and may be locally administered to a disease affected site, in a dose of 200 to 400 units per disease affected site. |
Inventor(s): | Motegi; Sei-ichiro (Gunma, JP) |
Assignee: | NATIONAL UNIVERSITY CORPORATION GUNMA UNIVERSITY (Gunma, JP) |
Application Number: | 15/941,089 |
Patent Claims: | see list of patent claims |
Details for Patent 10,478,478
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Solstice Neurosciences, Llc | MYOBLOC | rimabotulinumtoxinb | Injection | 103846 | 12/08/2000 | ⤷ Try a Trial | 2037-03-31 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |